GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ENLIE Pharmaceutical JSC (HSTC:BCP) » Definitions » EBITDA Margin %

ENLIE Pharmaceutical JSC (HSTC:BCP) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is ENLIE Pharmaceutical JSC EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ENLIE Pharmaceutical JSC's EBITDA for the six months ended in . 20 was ₫0.00 Mil. ENLIE Pharmaceutical JSC's Revenue for the six months ended in . 20 was ₫0.00 Mil. Therefore, ENLIE Pharmaceutical JSC's EBITDA margin for the quarter that ended in . 20 was 0.00%.


ENLIE Pharmaceutical JSC EBITDA Margin % Historical Data

The historical data trend for ENLIE Pharmaceutical JSC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENLIE Pharmaceutical JSC EBITDA Margin % Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
EBITDA Margin %

ENLIE Pharmaceutical JSC Semi-Annual Data
EBITDA Margin %

Competitive Comparison of ENLIE Pharmaceutical JSC's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENLIE Pharmaceutical JSC's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's EBITDA Margin % falls into.



ENLIE Pharmaceutical JSC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ENLIE Pharmaceutical JSC's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

ENLIE Pharmaceutical JSC's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENLIE Pharmaceutical JSC  (HSTC:BCP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


ENLIE Pharmaceutical JSC EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of ENLIE Pharmaceutical JSC's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ENLIE Pharmaceutical JSC (HSTC:BCP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.

ENLIE Pharmaceutical JSC (HSTC:BCP) Headlines

No Headlines